Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HNMPA is a membrane impermeable inhibitor of insulin receptor tyrosine kinase. HNMPA inhibits tyrosine and serine autophosphorylation by the human insulin receptor. HNMPA exhibits no effect on cyclic AMP-dependent protein kinase or protein kinase C activities.
説明 | HNMPA is a membrane impermeable inhibitor of insulin receptor tyrosine kinase. HNMPA inhibits tyrosine and serine autophosphorylation by the human insulin receptor. HNMPA exhibits no effect on cyclic AMP-dependent protein kinase or protein kinase C activities. |
In vitro | HNMPA reduces neuronal firing after GABA application and blocks GABA-dependent insulin inhibition[1]. HNMPA has no effect on cyclic AMP-dependent protein kinase or protein kinase C activities[2]. |
分子量 | 238.18 |
分子式 | C11H11O4P |
CAS No. | 132541-52-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (230.92 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HNMPA 132541-52-7 Tyrosine Kinase/Adaptors IGF-1R Inhibitor serine autophosphorylation tyrosine autophosphorylation tyrosine kinase Insulin Receptor inhibit inhibitor